Filing metadata

Accession number
0001209191-21-026669
Form type
Form 4
Filer
Keros Therapeutics, Inc.
CIK
CIK 1664710
Filed
Apr 14, 2021
Reporting period
Apr 12, 2021
Description
Insider transaction

Explore SEC Filings Hub